Proclara Biosciences Inc Headquarters
Looking for information about Proclara Biosciences Inc Headquarters? The links below have collected all the necessary data.
https://www.proclarabio.com/
Proclara is pioneering a new approach to treating neurodegenerative diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by Alzheimer’s, Parkinson’s, and other diseases caused by protei
http://www.proclarabio.com/about/
About Proclara Biosciences Proclara is a clinical-stage biotechnology company pioneering a breakthrough approach to treating neurodegenerative and peripheral protein misfolding diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected ...
https://www.crunchbase.com/organization/neurophage-pharmaceuticals
Legal Name Proclara Biosciences, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number 1 (617) 714-5468. NeuroPhage Pharmaceuticals, Inc. is a biotechnology company, develops disease-modifying therapies for the treatment of neurodegenerative diseases. The company develops a protein disaggregation platform for the ...Founded: 2006
https://www.bloomberg.com/profile/company/0206951D:US
ProClara Biosciences Inc NeuroPhage Pharmaceuticals Inc., is a pharmaceutical company. The Company develops protein dissaggregation platform for the treatment of neurodegenerative diseases.Founded: Dec 28, 2006
https://www.bbb.org/us/ma/cambridge/profile/pharmacy/proclara-biosciences-inc-0021-413474
Proclara Biosciences, Inc. Pharmacy. Business Profile. Proclara Biosciences, Inc. 222 3rd St # 3120. ... Inc., separately incorporated Better Business Bureau organizations in the US, Canada and ...
https://pitchbook.com/profiles/company/51637-69
Jan 14, 2015 · Proclara Biosciences General Information Description. Developer of disease-modifying therapies designed to be used for the treatment of neurodegenerative diseases. The company's therapies recognize and target multiple misfolded proteins, enabling clinicians to make a transformative impact on the lives of patients affected by Alzheimer's, Parkinson's and systemic amyloidosis.
https://www.biocentury.com/companies/proclara_biosciences_inc
Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more.
https://www.zoominfo.com/c/proclara-biosciences-inc/399460213
Proclara Biosciences, headquartered in Cambridge, Massachusetts, and established in 2007, is a clinical-stage biotechnology company developing novel therapies t... Read More Headquarters:
https://index.co/company/proclara-biosciences
Sep 09, 2016 · Headquarters Explore Cambridge $47,000,000 Venture capital (Series E) FinSMEs. Proclara Biosciences Secures $47M in Series E Financing Funding. Proclara Biosciences.
Have you found Proclara Biosciences Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.
Related Pages:
|
Recently Added Pages:
|